ReviewBMC neuroscience2008

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease.

Leah R Hanson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.